EUROPE – COM: Availability and applicability of the EFSA/ECHA guidance on identifying endocrine disruptors

The Commission notice of 24th September 2018 indicates that the new EFSA/ECHA guidance document on how to identify endocrine disruptors, adopted and published in June 2018, will apply as of the date of application of Regulation (EU) No. 2018/605, 10th November 2018, to address points 3.6.5 and 3.8.2 of Annex II of Regulation (EC) No. 1107/2009.

EFSA/ECHA guidance document and the scientific criteria to identify endocrine disruptors, as defined in Regulation (EU) No. 2018/605, will apply to on-going and future applications for approval or renewal of active substances, safeners or synergists.

 

To download:

Commission notice about the availability and applicability of a guidance document to implement Points 3.6.5 and 3.8.2 of Annex II of Regulation (EC) No 1107/2009 of the European Parliament and of the Council as regards endocrine disrupting properties (24/09/2018)

 

See also our previous articles:

EUROPE: Publication of the guidance document EFSA/ECHA on identifying endocrine disruptors

EUROPE: Publication of Endocrine disruptors criteria

 

Lynxee consulting’s team is at your disposal to answer your questions.

Contact us! http://lynxee.consulting/en/contact/

 

EUROPE: Draft report of the PEST Committee on the Union’s authorisation procedure for pesticides

Nine years after the adoption of Regulation (EC) No. 1107/2009 and following the recent controversy about the renewal of the active substance glyphosate, a special committee, the so-called ‘PEST’, was mandated in 2018 by the European Parliament for an analysis of the current authorisation procedure for pesticides in the Union. The final objective of the committee is to present recommendations on the procedure in order to achieve a high level of protection of human and animal health, and the environment.

A draft version of the PEST committee report has recently been made available online (please refer to the link below). A final version of the report is to be expected by the end of the year.

 

To download:

Draft report of the PEST Committee (25 August 2018)

 

Lynxee consulting’s team is at your disposal to answer your questions.

Contact us! http://lynxee.consulting/en/contact/

 

EUROPE – EFSA: Recurring issues in mammalian toxicology

During the EFSA peer review of pesticide active substances under Regulation (EC) No. 1107/2009, several aspects in the area of mammalian toxicology were identified by EFSA that needed discussion with experts from National Authorities in order to enhance the harmonisation of the risk assessment of active substances.

A new discussion was held at the Pesticide Peer Review Meeting 170 of December 2017. Recommendations were made on:

  • Genotoxicity of plant protection products
  • Use of (Q)SARs
  • Use of Read-Across approaches for metabolites

These recommendations will be applied during the EFSA peer review of the active substances.

 

In addition, brief discussions of the following topics were also made:

  • EFSA guidance 2016 on the residue definition
  • EFSA guidance 2017 on dermal absorption
  • Current and planned EFSA activities in the area of pesticides:
    • Developmental neurotoxicity
    • Cumulative assessment groups
    • Epidemiology
    • Planned workshops (in vitro comparative metabolism, phototoxicity, historical control data)
    • Update of EFSA guidance 2014 on the assessment of exposure of operators, workers, residents and bystanders

 

To download:

EFSA Technical Report – Outcome of the pesticides peer review meeting on general recurring issues in mammalian toxicology (25 August 2018)

 

See also our previous articles:

EUROPE – EFSA: Recurring issues in mammalian toxicology

 

Lynxee consulting’s team is at your disposal to answer your questions.

Contact us! http://lynxee.consulting/en/contact/

 

FRANCE: Withdrawal and restrictions on the use of neonicotinoid-based PPPs

Further to the adoption in May 2018 of three European regulations limiting the authorisations of imidacloprid, clothianidin and thiamethoxam products (Regulations (EU) No. 2018/783, No. 2018/784 and No. 2018/785) for use under permanent greenhouse or in seed treatment intended to be used only in permanent greenhouse, ANSES has withdrawn 19 approvals or parallel trade permits for products only authorised for field application or for the treatment of seeds intended for use in open field. ANSES also restricted 17 approvals to limit them to greenhouse uses. These withdrawals and modifications of the conditions of use are effective as from 1st September 2018.
Concurrently and in addition to these European provisions, in compliance with Decree 2018-675 of 30 July 2018, the use of acetamiprid, clothianidin, imidacloprid, thiacloprid and thiamethoxam-based products is prohibited in France from 1st September  2018 including for greenhouse uses that remain authorised in the European regulations. The French E-phy database has been updated accordingly for the plant protection products concerned.

To download: List of PPPs based on substances belonging to the neonicotinoids family and withdrawn from the market as from 1st September 2018 (in French)

See also our previous articles:

FRANCE: List of neonicotinoids substances banned

EUROPE: Neonicotinoids ban for outdoor uses

Lynxee consulting’s team is at your disposal to answer your questions.

Contact us! http://lynxee.consulting/en/contact/